Subsidiary Faces Drug License Suspension Overstore in Karnataka
Medplus Health Services Limited's subsidiary, Optival Health Solutions Private Limited, has received a suspension order concerning a Drug License for one of its stores located in the state of Karnataka. The action relates to a regulatory directive from drug control authorities and carries an estimated financial impact on the entity.The suspension was issued by the Assistant Director of Drugs Control Administration, Vijayapura Circle, regarding the store situated at Indi Sindagi Road Bijapur, Karnataka. Optival Health Solutions Private Limited received the order on July 18, 2026.
The action was taken in relation to a violation committed under Rule 65 of the Drugs and Cosmetics Act, 1940, and the corresponding Rules, 1945. The regulatory body ordered the suspension of the Drug License for two days.
The impact on financial operations resulting from this license suspension is quantified as a potential revenue loss of Rs 0.53 lacs.
MEDPLUS Stock Price Movement
On Friday, Medplus Health Services Limited shares slipped by 0.79% to close at ₹801.10. The stock traded within a day range of ₹798.95 and ₹817.55, registering a volume of 68,286 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.